article thumbnail

Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation

Medical Xpress

Although genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mutations continue to face a high risk of cancer incidence after age 50, even if they have not been previously diagnosed with cancer. Bloomberg Faculty of Nursing.

article thumbnail

Helix web tool guides prostate cancer genetic testing

pharmaphorum

A web-based digital tool called Helix could help clinicians identify patients with prostate cancer who would benefit from genetic testing and counselling, according to researchers in the US. ” The post Helix web tool guides prostate cancer genetic testing appeared first on. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

On the front lines: Correctional nurses and the COVID-19 pandemic

Bioengineer

New Rochelle, NY, July 14, 2021-Firsthand reports from nurses in correctional facilities detail the challenges they faced during the COVID-19 pandemic. These firsthand accounts are reported in a special issue on correctional nursing in the Journal of Correctional Health Care. Credit: Mary Ann Liebert, Inc., publishers. liebertpub.

Nurses 52
article thumbnail

STAT+: A young boy’s nightmare diagnosis, and the $3 million one-time treatment that will likely save his life

STAT News

When the long-awaited moment arrived, a nurse helped Adam Hess loosen a tiny plastic clamp on an intravenous line leading to the chest of his son, who lay asleep in a bed at Boston Children’s Hospital.

article thumbnail

Vyjuvek Gets FDA Nod as First Topical Gene Therapy for Rare Skin Disease

XTalks

DEB is a genetic disorder characterized by very fragile skin that rips and blisters easily even from minor friction (like rubbing or scratching) or injury, resulting in open wounds that are prone to skin infections and fibrosis. Vyjuvek is also the first drug approved to treat the disease and is Krystal’s first approved product.

article thumbnail

BASE10 and DNA Link Partners on Research to Support Authorization of Antibody Test at the Point of Care

The Pharma Data

26, 2020 /PRNewswire/ — BASE10 Genetics and DNA Link today announced their collaboration on a research project to evaluate the usability of DNA Link ‘ s AccuFind COVID-19 IgG antibody test in a healthcare setting. About BASE10 Genetics, Inc. SOURCE BASE10 Genetics, Inc. CHICAGO , Nov. About DNA Link, Inc.

DNA 52
article thumbnail

23andMe makes $400m telehealth play, gulping down Lemonaid

pharmaphorum

The company is best known for its saliva-based health and ancestry DNA testing targeted at consumers, but also uses its genetic database to look for new targets for drug development. The transaction is expected to close before the end of the year.

DNA 110